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Abstract
Introduction Our goal was to assess the effects of titration of a
norepinephrine infusion to increasing levels of mean arterial
pressure (MAP) on sublingual microcirculation.
Methods Twenty septic shock patients were prospectively
studied in two teaching intensive care units. The patients were
mechanically ventilated and required norepinephrine to maintain
a mean arterial pressure (MAP) of 65 mmHg. We measured
systemic hemodynamics, oxygen transport and consumption
(DO2  and VO2), lactate, albumin-corrected anion gap, and
gastric intramucosal-arterial PCO2  difference (ΔPCO2).
Sublingual microcirculation was evaluated by sidestream
darkfield (SDF) imaging. After basal measurements at a MAP of
65 mmHg, norepinephrine was titrated to reach a MAP of 75
mmHg, and then to 85 mmHg. Data were analyzed using
repeated measurements ANOVA and Dunnett test. Linear
trends between the different variables and increasing levels of
MAP were calculated.
Results Increasing doses of norepinephrine reached the target
values of MAP. The cardiac index, pulmonary pressures,
systemic vascular resistance, and left and right ventricular stroke
work indexes increased as norepinephrine infusion was
augmented. Heart rate, DO2  and VO2, lactate, albumin-
corrected anion gap, and ΔPCO2 remained unchanged. There
were no changes in sublingual capillary microvascular flow index
(2.1 ± 0.7, 2.2 ± 0.7, 2.0 ± 0.8) and the percent of perfused
capillaries (72 ± 26, 71 ± 27, 67 ± 32%) for MAP values of 65,
75, and 85 mmHg, respectively. There was, however, a trend to
decreased capillary perfused density (18 ± 10,17 ± 10,14 ± 2
vessels/mm2, respectively, ANOVA P = 0.09, linear trend P =
0.045). In addition, the changes of perfused capillary density at
increasing MAP were inversely correlated with the basal
perfused capillary density (R2 = 0.95, P < 0.0001).
Conclusions Patients with septic shock showed severe
sublingual microcirculatory alterations that failed to improve with
the increases in MAP with norepinephrine. Nevertheless, there
was a considerable interindividual variation. Our results suggest
that the increase in MAP above 65 mmHg is not an adequate
approach to improve microcirculatory perfusion and might be
harmful in some patients.
Introduction
Septic shock is characterized by severe vasodilation and
hypotension refractory to aggressive fluid resuscitation [1].
Despite the normalization of cardiac output, evidence of tissue
hypoperfusion is frequently present. Accordingly, organ dys-
functions usually develop despite normal or increased oxygen
transport (DO2). Microcirculatory alterations could be an
underlying explanation for these findings [2]. Experimental
models of resuscitated septic shock show that microvascular
perfusion is altered despite the normalization of systemic and
regional hemodynamics [3]. In addition, septic patients sys-
tematically exhibit severe disorders in sublingual microcircula-
ANOVA: analysis of variance; DO2: oxygen transport; MAP: mean arterial pressure; MFI: microvascular flow index; PCO2: partial pressure of carbon 
dioxide; ΔPCO2: gastric intramucosal-arterial PCO2 difference; PO2: partial pressure of oxygen; SDF: sidestream darkfield.Critical Care    Vol 13 No 3    Dubin et al.
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tion that are strongly associated with organ failures and
outcome [4,5]. The ability to improve sublingual microcircula-
tion has also been related to survival [5]. Moreover, sublingual
perfusion might be enhanced by different therapeutic strate-
gies that include the use of vasoactive drugs [6,7]. In this way,
improving microcirculation might be an important goal in the
resuscitation of patients with septic shock.
An approach to improve microcirculation is to increase the
perfusion pressure. When the mean arterial pressure (MAP)
decreases below an autoregulatory threshold of about 60 to
65 mmHg, organ perfusion becomes pressure dependent [8].
Nevertheless, intravascular thrombosis and vasoconstrictor
mediators, along with regional deficiencies in nitric oxide pro-
duction, could alter vascular reactivity and shift the autoregu-
latory threshold to higher values [9,10]. Consequently, the
increase in MAP could improve tissue perfusion. Clinical stud-
ies, however, have shown that the elevation in MAP beyond 65
mmHg fails to increase systemic oxygen metabolism, skin
microcirculatory blood flow, urine output, splanchnic per-
fusion, or renal function [11,12]. The experimental evidence
regarding this issue, however, is controversial [13-17].
Our goal was to assess the effects of titration of a norepine-
phrine infusion to increasing levels of MAP on sublingual
microcirculation. We hypothesized that the increase in MAP
from 65 to 75 mmHg, and then to 85 mmHg does not improve
sublingual microcirculatory blood flow. At the time of submis-
sion of this manuscript, a very similar study was published
[18], which reported that escalating doses of norepinephrine
in septic patients increased DO2 and tissue oxygenation, and
were not associated with significant changes in preexisting
sublingual microvascular alterations. The results of our study
confirm these previous findings, but suggest that the individual
responses are related to the basal microcirculatory condition.
Materials and methods
The protocol was approved by the Institutional Review Boards
of Sanatorio Otamendi and Clínica Bazterrica. Informed con-
sent was obtained from the next of kin of all patients admitted
to the study.
Setting
This study was conducted in two teaching intensive care units.
Patients
The study population included 20 septic shock patients [19]
requiring norepinephrine despite adequate fluid resuscitation
to maintain a MAP of 65 mmHg or higher (Table 1). They were
mechanically ventilated in controlled mode and received infu-
sions of midazolam and fentanyl. All patients had a systemic
arterial catheter and a pulmonary artery catheter inserted. A
tonometric nasogastric tube was placed into the stomach
(TRIP NGS Catheter, Tonometrics, Worcester, MA, USA),
after which radiographic confirmation of catheter position was
obtained. All patients received intravenous ranitidine. The clin-
ical characteristics of the patients are presented in Table 1.
Measurements and derived calculations
Serial measurements of heart rate, MAP, mean arterial pulmo-
nary pressure, pulmonary artery occlusion pressure, and cen-
tral venous pressure were performed. Transducers were
referenced to the midaxillary line and all pressures were taken
at end-expiration. Cardiac output was measured by thermodi-
lution using three injections of saline solution (10 cc) at room
temperature.
Arterial, mixed venous, and central venous blood samples
were analyzed for gases, hemoglobin, and oxygen saturation
(AVL OMNI 9, Roche Diagnostics, Graz, Austria). Sodium
(Na), potassium (K) and chloride (Cl) ions (selective electrode
ion, AEROSET, Abbott Laboratories, Abbott Park, IL, USA),
albumin (Bromcresol-sulfonphthaleinyl), and lactate (selective
electrode ion, AVL OMNI 9) were measured in arterial blood
samples. The albumin-corrected anion gap was calculated
[20] as: 
Derived hemodynamic and DO2 variables were calculated
according to standard formulae.
Intramucosal partial pressure of carbon dioxide (PCO2) was
measured with a tonometer using an automated air tonometry
system (Tonocap; Datex Ohmeda, Helsinki, Finland). Its value
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Table 1
Clinical and epidemiological characteristics of the patients
Age, years 72 ± 12
Gender, % male 55
SOFA score 9.8 ± 2.8
APACHE II score 24.4 ± 5.4
APACHE II predicted risk mortality 50.8 ± 17.5
Actual mortality, % 50
Source of sepsis, n (%)
Pneumonia 9 (45)
Intra-abdominal infection 3 (15)
Primary bacteremia 3 (15)
Endovascular infection 2 (10)
Cellulitis 2 (10)
Urinary tract infection 1 (5)
Fluid balance on the previous day, ml 4592 ± 3156
Fluid administration on the previous day, ml 6183 ± 2601
APACHE = Acute Physiology and Chronic Health Evaluation; SOFA 
= Sepsis-related Organ Failure Assessment.Available online http://ccforum.com/content/13/3/R92
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was used to calculate the intramucosal-arterial PCO2 differ-
ence (ΔPCO2).
Microvideoscopic measurements and analysis
The microcirculatory network was evaluated in the sublingual
mucosa using a sidestream dark field (SDF) imaging device
(Microscan®, MicroVision Medical, Amsterdam, Netherlands)
[21].
Different cautions and steps were followed to obtain images of
adequate quality and to ensure good reproducibility. Video
acquisition and image analyses were performed by well-
trained researchers (AD, MOP and VSKE). After gentle
removal of saliva by isotonic-saline-drenched gauze, steady
images of at least 20 seconds were obtained while avoiding
pressure artifacts using a portable computer and an analog/
digital video converter (ADVC110, Canopus Co, San Jose,
CA, USA). Video clips were stored as AVI files to allow com-
puterized frame-by-frame image analysis. SDF images were
acquired from at least five different sites. Adequate focus and
contrast adjustment were verified, and images of poor quality
were discarded. The entire sequence was used to character-
ize the semi-quantitative characteristics of microvascular
blood flow, particularly the presence of stopped or intermittent
flow.
Video clips were analyzed blindly and randomly using different
approaches. First, we used a previously validated semi-quanti-
tative score [22]. It distinguishes between no flow (0), intermit-
tent flow (1), sluggish flow (2), and continuous flow (3) [22]. A
value was assigned to each individual vessel. The overall
score, called the microvascular flow index (MFI), is the average
of the individual values. For each patient, the values from five
to eight videos were averaged. In addition, vascular density
was quantified as the number of vessels per mm2. To deter-
mine heterogeneity of perfusion in each territory, the flow het-
erogeneity index was calculated as the highest MFI minus the
lowest MFI divided by the mean MFI [23]. These quantifica-
tions of flow were made per group of vessel diameter: small
(capillaries), 10 to 20 μm; medium, 21 to 50 μm; and large, 51
to 100 μm. Finally, the percentage of perfused vessels and the
total and capillary perfused vascular densities were calculated
[4,24]. The percentage of perfused vessels was calculated as
the number of vessels with flow 2 and 3 divided by the total
number of vessels multiplied by 100.
Study protocol
After fluid resuscitation failed to improve MAP, a norepine-
phrine infusion was adjusted to reach a MAP of 65 mmHg in
all patients. After a period of at least two hours in which the
requirement of norepinephrine to maintain a MAP of 65 mmHg
remained unchanged, the measurements were performed.
Norepinephrine was then titrated to reach a MAP of 75 mmHg.
After 30 minutes at this MAP, new measurements were taken.
Finally, norepinephrine infusion was increased to achieve a
MAP of 85 mmHg and, after 30 minutes at this MAP, a final set
of measurements were taken.
No additional sedation, antipyretics or vasoactive drugs were
administered during the study period. The infusions of mida-
zolam and fentanyl were kept constant at rates of 0.99 ± 0.22
mg/kg/hour and 0.82 ± 0.20 μg/kg/hour, respectively.
Analysis of data
After showing a normal distribution, data were analyzed using
repeated measurements analysis of variance (ANOVA) and
Table 2
Changes in hemodynamic, oxygen transport, and tonometric variables as mean arterial pressure was increased from 65 mmHg to 85 
mmHg with norepinephrine
Mean arterial blood pressure ANOVA Linear trend
65 mmHg 75 mmHg 85 mmHg PP
Norepinephrine doses (μg/kg/min) 0.48 ± 0.43 0.65 ± 0.68* 0.74 ± 0.67* < 0.0001 < 0.0001
Heart rate (beats/min) 94 ± 21 92 ± 18 93 ± 18 0.59 0.43
Mean arterial blood pressure (mmHg) 65 ± 2 76 ± 2* 85 ± 2* < 0.0001 < 0.0001
Mean pulmonary artery pressure (mmHg) 28 ± 7 30 ± 7* 30 ± 7* < 0.0001 < 0.0001
Pulmonary artery occlusion pressure (mmHg) 14 ± 4 15 ± 4 16 ± 4 0.06 0.02
Central venous pressure (mmHg) 11 ± 4 12 ± 4 12 ± 4 0.18 0.47
Cardiac index (l/min/m2) 2.98 ± 0.99 3.11 ± 1.07 3.23 ± 1.02* 0.0002 < 0.0001
Oxygen transport (ml/min/m2) 366 ± 137 379 ± 145 383 ± 166 0.53 0.28
Oxygen consumption (ml/min/m2) 100 ± 33 91 ± 31 90 ± 40 0.61 0.63
Intramucosal-arterial pCO2 (mmHg) 15 ± 15 16 ± 18* 16 ± 18 0.03 0.06
* P < 0.05 vs. basal (Dunnett post hoc test after repeated measures ANOVA).
ANOVA = analysis of variance; pCO2 = partial pressure of carbon dioxide.Critical Care    Vol 13 No 3    Dubin et al.
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Dunnett test. Linear trends between the different variables and
increasing levels of MAP were calculated [25]. A P < 0.05 was
considered significant. Data are showing as mean ± standard
deviation.
Results
Effects on hemodynamic and oxygen transport variables
Increasing doses of norepinephrine induced the target values
of MAP. Cardiac index and pulmonary pressures increased as
norepinephrine infusion was augmented. Heart rate, DO2 and
oxygen consumption remained unchanged (Table 2).
Effects on lactate and acid-base parameters
Arterial lactate levels were stable. Venous oxygen saturations
and pressures increased while other acid-base variables were
unmodified (Table 3).
Effects on gastric tonometry
ΔPCO2 did not change throughout the study (Table 2).
Effects on sublingual microcirculation
Although the total vascular density was not significantly
altered, there was a trend to a decreased capillary density
(ANOVA P = 0.09, linear trend P = 0.03; Table 4). The MFI
and the percentage of perfused vessels were unchanged in
the different types of vessels at increasing MAP values. The
total perfused vascular density was unmodified for MAP values
of 65, 75, and 85 mmHg (38 ± 14, 37 ± 15, 37 ± 4 vessels/
mm2, respectively, ANOVA P = 0.94, linear trend P = 0.76);
however, there was a trend to a decreased perfused capillary
density (18 ± 10, 17 ± 10, 14 ± 2 vessels/mm2, respectively,
ANOVA P = 0.09, linear trend P = 0.045). The heterogeneity
flow index also remained unchanged (Table 4). The individual
behaviour of capillary density, capillary MFI, percentage of per-
fused capillaries, perfused capillary density and capillary het-
erogeneity flow index are depicted in Figures 1 to 5. There
was, however, considerable interindividual variability. In partic-
ular, there was a strong linear relationship between the
changes of perfused capillary density, when MAP was
increased from baseline to 85 mmHg, with the basal perfused
capillary density at a MAP of 65 mmHg (Figure 6).
Discussion
The main finding of this study is that the increase in MAP with
norepinephrine failed to improve sublingual microcirculation,
or any other variable related to perfusion as arterial lactate,
anion gap, ΔPCO2, and parameters of oxygen metabolism.
Despite a trend to decreased total and perfused capillary den-
sity, there were considerable variations in the interindividual
responses that seem to depend on the basal condition of the
microcirculation.
The goal of vasopressor therapy is to improve tissue perfusion
pressure, while avoiding excessive vasoconstriction. Marik and
Mohedin showed that an infusion of norepinephrine titrated to
increase the MAP to more than 75 mmHg improved intramu-
cosal pH [26]. Martin and colleagues [27] and Desjars and
colleagues [28] reported significant increases in urine output
Table 3
Changes in arterial lactate, hemoglobin, blood gases and oxygen saturations as mean arterial pressure was increased from 65 
mmHg to 85 mmHg with norepinephrine
Mean arterial blood pressure ANOVA Linear trend
65 mmHg 75 mmHg 85 mmHg PP
Arterial lactate (mmol/L) 2.6 ± 2.8 2.4 ± 2.7 2.5 ± 2.7 0.27 0.32
Hemoglobin (g%) 9.6 ± 2.3 9.6 ± 2.4 9.6 ± 2.3 0.76 0.79
Arterial pH 7.26 ± 0.11 7.26 ± 0.11 7.26 ± 0.11 0.44 0.29
Arterial PCO2 (mmHg) 39 ± 10 39 ± 10 40 ± 11 0.73 0.57
Arterial PO2 (mmHg) 112 ± 48 113 ± 45 108 ± 34 0.39 0.25
Arterial HCO3
- (mmol/l) 18 ± 5 18 ± 5 18 ± 5 0.50 0.43
Arterial oxygen saturation 0.96 ± 0.02 0.96 ± 0.02 0.96 ± 0.03 0.67 0.44
Mixed venous pH 7.23 ± 0.11 7.24 ± 0.10 7.24 ± 0.10 0.78 0.49
Mixed venous PCO2 (mmHg) 45 ± 11 45 ± 11 45 ± 11 0.90 0.69
Mixed venous PO2 (mmHg) 42 ± 7 43 ± 7 44 ± 8* 0.04 0.02
Mixed venous HCO3
- (mmol/l) 19 ± 5 19 ± 5 19 ± 5 0.18 0.08
Mixed venous oxygen saturation 0.70 ± 0.08 0.72 ± 0.08* 0.73 ± 0.07* 0.01 0.005
Central venous oxygen saturation 0.74 ± 0.08 0.76 ± 0.08* 0.77 ± 0.08* 0.01 0.004
Arterial anion gap (mmol/L) 18 ± 6 19 ± 6 20 ± 7 0.16 0.06
* P < 0.05 vs. basal (Dunnett post hoc test after repeated measures ANOVA).
ANOVA = analysis of variance; HCO3 = bicarbonate; pCO2 = partial pressure of carbon dioxide; pO2 = partial pressure of oxygen.Available online http://ccforum.com/content/13/3/R92
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and improvements in renal function in septic shock. Neverthe-
less, in these studies [26-28] the initial MAP was below 60
mmHg, a value that is most likely beyond the lower limit of
autoregulation. On the other hand, Deruddre and colleagues
showed that increasing MAP from 65 to 75 mmHg with nore-
pinephrine in patients with septic shock increased urinary out-
put and decreased renal vascular resistance [29].
Our study is consistent with the results from LeDoux and col-
leagues [11] and Bourgoin and colleagues [12]. In these stud-
ies, the lack of change in any perfusion variable over a range
of 20 mmHg in MAP suggests that the patients were within
their autoregulatory range. Jhanji and colleagues have recently
demonstrated that increasing doses of norepinephrine
resulted in an increase in global DO2, and in cutaneous micro-
Table 4
Changes in microvascular variables as mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine
Mean arterial blood pressure ANOVA Linear trend
65 mmHg 75 mmHg 85 mmHg P P
Vascular density (vessels/mm2)
Large diameter vessels 11 ± 1 10 ± 3 10 ± 3 0.81 0.61
Medium diameter vessels 15 ± 3 16 ± 4 16 ± 4 0.82 0.53
Small diameter vessels 24 ± 8 23 ± 8 22 ± 1 0.09 0.03
Microvascular flow index
Large diameter vessels 2.3 ± 0.6 2.3 ± 0.8 2.2 ± 0.8 0.34 0.16
Medium diameter vessels 2.2 ± 0.7 2.2 ± 0.7 2.1 ± 0.9 0.79 0.52
Small diameter vessels 2.1 ± 0.7 2.2 ± 0.7 2.0 ± 0.8 0.69 0.47
Perfused vessels (%)
Large diameter vessels 82 ± 21 80 ± 28 87 ± 6 0.46 0.40
Medium diameter vessels 77 ± 27 77 ± 29 77 ± 6 0.98 1.00
Small diameter vessels 72 ± 26 71 ± 27 67 ± 32 0.55 0.38
Total vessels 75 ± 25 75 ± 27 76 ± 4 0.92 0.73
Heterogeneity flow index
Large diameter vessels 1.0 ± 0.5 1.3 ± 1.2 1.5 ± 1.4 0.07 0.02
Medium diameter vessels 1.6 ± 1.6 1.5 ± 1.4 1.7 ± 1.2 0.86 0.78
Small diameter vessels 1.8 ± 1.3 1.8 ± 1.2 1.7 ± 1.1 0.97 0.80
ANOVA = analysis of variance.
Figure 1
Individual behavior of the sublingual capillary density Individual behavior of the sublingual capillary density. Results are 
shown as the mean arterial pressure was increased from 65 mmHg to 
85 mmHg with norepinephrine.
Figure 2
Individual behavior of sublingual capillary microvascular flow index Individual behavior of sublingual capillary microvascular flow index. 
Results are shown as the mean arterial pressure was increased from 
65 mmHg to 85 mmHg with norepinephrine.Critical Care    Vol 13 No 3    Dubin et al.
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vascular flow and tissue partial pressure of oxygen (PO2) with-
out significant changes in sublingual microcirculation [18].
They also showed, however, that when MAP was augmented
from 70 to 90 mmHg, the MFI, proportion of perfused vessels,
and perfused vessel density fell by about 10%. The remarkable
similarity between the study by Jhanji and colleagues [18] and
the current study emphasizes the reproducibility of the tech-
niques and results.
In addition, our results expand previous knowledge by
addressing the variation of interindividual responses. In partic-
ular, the change in the perfused capillary density was strongly
dependent on the basal state of microcirculation. In this way,
perfused capillary density improved in patients with an altered
sublingual perfusion at baseline, and decreased in patients
with preserved basal microvascular perfusion. Sakr and col-
leagues described a similar microvascular response to red
blood cell transfusion [30]. Other studies have also shown that
vasopressors could decrease sublingual microcirculation
[31,32], suggesting that excessive vasoconstriction might be
deleterious to microcirculation.
Our study has several limitations. First, this observational study
lacks a control group. Each patient, therefore, served as his/
her own control. Second, the number of patients included in
this study was small. Despite the sample size, significant
Figure 3
Individual behavior of sublingual percentage of perfused capillaries Individual behavior of sublingual percentage of perfused capillaries. 
Results are shown as the mean arterial pressure was increased from 
65 mmHg to 85 mmHg with norepinephrine.
Figure 4
Individual behavior of sublingual perfused capillary density Individual behavior of sublingual perfused capillary density. Results are 
shown as the mean arterial pressure was increased from 65 mmHg to 
85 mmHg with norepinephrine.
Figure 5
Individual behaviour of sublingual capillary heterogeneity flow index Individual behaviour of sublingual capillary heterogeneity flow index. 
Results are shown as the mean arterial pressure was increased from 
65 mmHg to 85 mmHg with norepinephrine.
Figure 6
Relationship between the changes of perfused capillary density, when  mean arterial pressure (MAP) was increased from the baseline to a  MAP of 85 mmHg, with the basal perfused capillary density at a MAP of  65 mmHg Relationship between the changes of perfused capillary density, when 
mean arterial pressure (MAP) was increased from the baseline to a 
MAP of 85 mmHg, with the basal perfused capillary density at a MAP of 
65 mmHg.Available online http://ccforum.com/content/13/3/R92
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changes in hemodynamic variables developed. Conversely,
most parameters related to tissue perfusion and oxygenation
remained unchanged or had a trend to worsen. Third, the infu-
sion period was short. A longer period might have allowed the
appearance of changes not observed in the present study.
Nevertheless, most norepinephrine effects on hemodynamics
and on tissue perfusion and oxygenation are expected to be
evident within a few minutes. In addition, the short half-life of
norepinephrine allows a new steady state to be reached in its
plasmatic levels a few minutes after a change in the infusion
rate [33]. In fact, several hemodynamic changes appeared
shortly after each dose modification. Moreover, the infusion
period was deliberately kept short, to avoid the background
effects of changes in the underlying conditions of the patients.
With longer periods of evaluation, a time effect with spontane-
ous changes of the studied variables related to the natural his-
tory of the disease might not be ruled out. Finally, as a different
behaviour of microcirculatory beds is a characteristic of sepsis
[3,34], this study does not address the response of other ter-
ritories to increasing MAP.
Conclusions
In this observational study, patients with septic shock showed
severe microcirculatory alterations that failed to improve with
the increases in MAP with norepinephrine. Furthermore, linear
trend analysis showed reductions in the capillary and in the
perfused capillary densities. Nevertheless, interindividual
responses could be quite variable and dependent on the basal
state of the microcirculation. Our results suggest that the
increase in MAP above 65 mmHg is not a straightforward
treatment to improve microvascular perfusion. It might be
harmful for some patients, while benefiting others. Studies
including greater numbers of patients are needed to determine
the usefulness of individual titration of vasopressor therapy on
sublingual microcirculation.
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